Chen Q, Ishii K, Mori H, Nishijima A, Arai S, Miyazaki T
Nat Commun. 2024; 15(1):9387.
PMID: 39477921
PMC: 11525585.
DOI: 10.1038/s41467-024-53615-5.
Fujii T, Yamawaki-Ogata A, Terazawa S, Narita Y, Mutsuga M
Sci Rep. 2024; 14(1):15878.
PMID: 38982113
PMC: 11233551.
DOI: 10.1038/s41598-024-66791-7.
Cao Y, Hu B, Fan Y, Wang W, Chi M, Nasser M
Eur J Med Res. 2024; 29(1):21.
PMID: 38178221
PMC: 10765713.
DOI: 10.1186/s40001-023-01597-3.
Kotol D, Woessmann J, Hober A, Alvez M, Tran Minh K, Ponten F
Cancers (Basel). 2023; 15(19).
PMID: 37835457
PMC: 10571728.
DOI: 10.3390/cancers15194764.
Tanoue S, Kanmura S, Hinokuchi M, Arima S, Sasaki F, Hashimoto S
Biomed Rep. 2022; 17(4):82.
PMID: 36158321
PMC: 9468806.
DOI: 10.3892/br.2022.1565.
The Roles of Adipose Tissue Macrophages in Human Disease.
Liang W, Qi Y, Yi H, Mao C, Meng Q, Wang H
Front Immunol. 2022; 13:908749.
PMID: 35757707
PMC: 9222901.
DOI: 10.3389/fimmu.2022.908749.
Does Proteomic Mirror Reflect Clinical Characteristics of Obesity?.
Kiseleva O, Arzumanian V, Poverennaya E, Pyatnitskiy M, Ilgisonis E, Zgoda V
J Pers Med. 2021; 11(2).
PMID: 33494491
PMC: 7912072.
DOI: 10.3390/jpm11020064.
Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer.
Huang W, Wang X, Zhang M, Li L, Wang R
BMC Gastroenterol. 2020; 20(1):373.
PMID: 33172404
PMC: 7654032.
DOI: 10.1186/s12876-020-01520-8.
Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Sumida Y, Yoneda M, Seko Y, Ishiba H, Hara T, Toyoda H
Diagnostics (Basel). 2020; 10(8).
PMID: 32785100
PMC: 7459689.
DOI: 10.3390/diagnostics10080579.
AIM-deficient mouse fed a high-trans fat, high-cholesterol diet: a new animal model for nonalcoholic fatty liver disease.
Komatsu G, Nonomura T, Sasaki M, Ishida Y, Arai S, Miyazaki T
Exp Anim. 2018; 68(2):147-158.
PMID: 30487357
PMC: 6511520.
DOI: 10.1538/expanim.18-0108.
Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease.
Himoto T, Fujita K, Nomura T, Tani J, Morishita A, Yoneyama H
Diabetol Metab Syndr. 2017; 9:45.
PMID: 28630652
PMC: 5470186.
DOI: 10.1186/s13098-017-0243-z.
The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.
Ono Y, Kanmura S, Morinaga Y, Oda K, Kawabata K, Arima S
BMC Gastroenterol. 2017; 17(1):40.
PMID: 28284201
PMC: 5346245.
DOI: 10.1186/s12876-017-0591-z.
Impact of feline AIM on the susceptibility of cats to renal disease.
Sugisawa R, Hiramoto E, Matsuoka S, Iwai S, Takai R, Yamazaki T
Sci Rep. 2016; 6:35251.
PMID: 27731392
PMC: 5059666.
DOI: 10.1038/srep35251.
MafB deficiency accelerates the development of obesity in mice.
Tran M, Hamada M, Nakamura M, Jeon H, Kamei R, Tsunakawa Y
FEBS Open Bio. 2016; 6(6):540-7.
PMID: 27419056
PMC: 4887969.
DOI: 10.1002/2211-5463.12058.
Retinol-binding protein 4 and its potential roles in hypercholesterolemia revealed by proteomics.
Jugnam-Ang W, Pannengpetch S, Isarankura-Na-Ayudhya P, Thippakorn C, Isarankura-Na-Ayudhya C, Lawung R
EXCLI J. 2016; 14:999-1013.
PMID: 27103892
PMC: 4834671.
DOI: 10.17179/excli2015-478.
Association of apoptosis inhibitor of macrophage (AIM) expression with urinary protein and kidney dysfunction.
Oshima M, Iwata Y, Furuichi K, Sakai N, Shimizu M, Hara A
Clin Exp Nephrol. 2016; 21(1):35-42.
PMID: 26846784
DOI: 10.1007/s10157-016-1240-5.
Apoptosis inhibitor of macrophage protein enhances intraluminal debris clearance and ameliorates acute kidney injury in mice.
Arai S, Kitada K, Yamazaki T, Takai R, Zhang X, Tsugawa Y
Nat Med. 2016; 22(2):183-93.
PMID: 26726878
DOI: 10.1038/nm.4012.
The Development of Animal Nutrition and Metabolism and the Challenges of Our Time.
Arai T
Front Vet Sci. 2015; 1:23.
PMID: 26664922
PMC: 4668864.
DOI: 10.3389/fvets.2014.00023.
Interaction of AIM with insulin-like growth factor-binding protein-4.
You Q, Wu Y, Yao N, Shen G, Zhang Y, Xu L
Int J Mol Med. 2015; 36(3):833-8.
PMID: 26135353
PMC: 4533773.
DOI: 10.3892/ijmm.2015.2262.
Circulating AIM as an indicator of liver damage and hepatocellular carcinoma in humans.
Yamazaki T, Mori M, Arai S, Tateishi R, Abe M, Ban M
PLoS One. 2014; 9(10):e109123.
PMID: 25302503
PMC: 4193837.
DOI: 10.1371/journal.pone.0109123.